Associated tags: PR, IBD, CCM, Inflammation, Biotechnology, Calprotectin, Cortisol, Medical imaging, Pharmaceutical industry, C-reactive protein, Health, Inflammatory bowel disease, CRP, Patient, IL6, Biomarker, Interleukin 6, Skin, Data Management, University, Science, Other Health, Professional Services
Locations: TEXAS, UNITED STATES, NORTH AMERICA, MOUNT SINAI, DALLAS
Technology,
Medical Devices,
Health Technology,
Nanotechnology,
Other Health,
Biotechnology,
Hardware,
Managed Care,
Health,
Data Management,
Moses Austin,
Conditional sentence,
University,
Professor,
IL-6,
Perspiration,
Patient,
Inflammation,
Biomarker,
Research,
AI,
Doctor of Philosophy,
Senior,
IBD,
Translation,
Management,
C-reactive protein,
Inflammatory bowel disease,
Inflammatory Bowel Diseases,
Trial of the century,
CRP,
Pharmaceutical industry The study showcases the IBD Aware device's ability to non-invasively monitor calprotectin levels in both active and remission phases of IBD.
Key Points:
- The study showcases the IBD Aware device's ability to non-invasively monitor calprotectin levels in both active and remission phases of IBD.
- These results not only affirm the accuracy of the IBD Aware device, but demonstrate its utility in the shifting paradigm of proactive IBD management that emphasizes continuous, data-driven decision-making.
- “The IBD Aware device exemplifies our dedication to empowering healthcare professionals and enhancing patient outcomes through remote and continuous monitoring."
- EnLiSense is pioneering work to build a future where proactive, personalized, and precision remote patient monitoring becomes the standard in chronic disease management.
Wearables,
Mobile Technology,
Technology,
Mental Health,
Fitness & Nutrition,
Health Technology,
Other Health,
Health,
General Health,
Consumer Electronics,
Moses Austin,
Benchmarking,
Hormone,
Exercise,
Professor,
Inflammation,
Biomarker,
Research,
Sleep,
Melatonin,
University,
Doctor of Philosophy,
Life,
Eye,
Diet,
Management,
Publication,
Skin,
Cortisol,
Ageing,
Medical device The wearable features its proprietary passive-sweat sensor technology that non-invasively rests on your skin, day and night, continuously measuring biomarker levels.
Key Points:
- The wearable features its proprietary passive-sweat sensor technology that non-invasively rests on your skin, day and night, continuously measuring biomarker levels.
- Now, it provides users with unmatched real-time insights into their wellness, establishing a new benchmark for the continuous monitoring of these critical biomarkers.
- Corti redefines health monitoring by offering continuous, real-time visibility into the body's key stress and sleep hormones, Cortisol and Melatonin, marking a first in the wearable market.
- Moreover, we are actively working with partnering businesses to discover new applications, enhancing its integration into various health and wellness ecosystems.
Retrieved on:
Thursday, February 15, 2024
Hardware,
Health Technology,
Data Management,
Other Health,
Technology,
Professional Services,
Biometrics,
Medical Devices,
Genetics,
Artificial Intelligence,
Wearables,
Mobile Technology,
Biotechnology,
Science,
Data Analytics,
Research,
Health,
Biosensor,
Digital health,
Ulcerative colitis,
Senior,
Doctor of Philosophy,
Translation,
Hasso Plattner Institute,
Moses Austin,
MD,
Professor,
Inflammation,
Blood,
IL-6,
Quality of life,
Bioelectronics,
Gastrointestinal tract,
Trial of the century,
Scientific Reports,
Management,
University,
Perspiration,
CRP,
Clinical,
Inflammatory bowel disease,
Patient,
Biological engineering,
Optimism,
IBD,
Conditional sentence,
TNF,
Endoscopy,
National Institutes of Health,
Medical imaging Our innovative IBD Aware device offers the first solution for continuous, non-invasive monitoring of IBD through the power of sweat-sensing technology.
Key Points:
- Our innovative IBD Aware device offers the first solution for continuous, non-invasive monitoring of IBD through the power of sweat-sensing technology.
- EnLiSense's journey reaches a significant milestone with over half a million human biomarker readings, underscoring the extensive validation of our technology.
- These readings provide crucial data points, enhancing the precision and trustworthiness of inflammatory biomarker monitoring.
- The studies involved measuring inflammation markers CRP, TNF-α, and IL-6 in subjects' blood and sweat continuously in subjects with and without IBD.
Retrieved on:
Wednesday, October 4, 2023
Technology,
Biotechnology,
Health,
Other Health,
Professional Services,
Research,
Medical Devices,
Software,
General Health,
Data Analytics,
Genetics,
Health Technology,
Science,
Data Management,
Brain-derived neurotrophic factor,
University,
Crohn's & Colitis Foundation,
GFAP,
IBD,
University of Texas at Austin,
Melatonin,
Interleukin 6,
Biomarker,
Glial fibrillary acidic protein,
IL6,
University of Glasgow,
Crohn's disease,
Patient,
CRP,
Physician,
Conditional sentence,
Inflammatory bowel disease,
BDNF,
Glucose,
Skin,
C-reactive protein,
Pharmaceutical industry,
Medical imaging,
Cortisol,
Calprotectin,
CCM Patients and clinicians are now actively being enrolled in these studies, marking a pivotal phase in EnLiSense's journey towards revolutionizing chronic disease management.
Key Points:
- Patients and clinicians are now actively being enrolled in these studies, marking a pivotal phase in EnLiSense's journey towards revolutionizing chronic disease management.
- The IBD Aware system, a cornerstone of EnLiSense's innovative approach, continuously monitors key inflammatory biomarkers by gently resting on a patient’s skin sampling just nano-liters of passive sweat.
- This non-invasive, wearable technology empowers both clinicians and patients with real-time data, facilitating personalized, data-driven, proactive management of chronic diseases like IBD.
- Dr. Sriram Muthukumar, CEO of EnLiSense CCM, reflects on the early findings, stating, "The initial validation data is indeed very encouraging.
Retrieved on:
Wednesday, April 12, 2023
Health Technology,
Other Consumer,
Biotechnology,
Finance,
Women,
Seniors,
Other Science,
Health,
Research,
Professional Services,
Men,
Consumer,
Other Technology,
Nanotechnology,
Wearables,
Mobile Technology,
Science,
Other Health,
Hardware,
Data Management,
Managed Care,
Telemedicine,
Virtual Medicine,
General Health,
Technology,
Biometrics,
Medical Devices,
Translation,
University,
Icahn School of Medicine at Mount Sinai,
IBD,
AWARE,
Quality of life,
Cortisol,
Mount Sinai,
Interleukin 6,
Inflammation,
Biomarker,
IL6,
Inflammatory bowel disease,
Organization,
Patient,
Investment,
CRP,
Risk,
Recurrence,
Perspiration,
Skin,
Disease,
C-reactive protein,
Financial adviser,
Medical imaging,
Pharmaceutical industry,
Calprotectin IBD AWARE is an inflammation tracker targeting key biomarkers associated with inflammatory bowel disease (IBD).
Key Points:
- IBD AWARE is an inflammation tracker targeting key biomarkers associated with inflammatory bowel disease (IBD).
- Additional details about the IBD AWARE platform and how it works can be found at https://www.ibdwearable.com .
- “IBD AWARE will provide patients and their clinicians with the real-time, actionable data they need to further quality of life outcomes.
- The Crohn’s & Colitis Foundation launched IBD Ventures to accelerate the discovery and development of research-based products with the potential to address unmet needs of IBD patients.
